 |
|
vitespen
An autologous cancer vaccine derived from tumor-specific gp96 heat shock proteins. Heat shock proteins chaperone peptides through the endoplasmic reticulum, are key regulators of dendritic cell maturation, migration and antigen processing, and are involved in T-cell activation. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | autologous gp96 heat shock protein peptide complex vaccine
gp96 HSP-peptide complex
heat shock protein peptide complex-96 | | | | US brand name: | | Oncophage | | | | Code name: | | HSPPC-96 | | |
|
|
